[
    [
        {
            "time": "",
            "original_text": "中银国际医药首席分析师邓周宇：看好血液制品、原料药及中间体细分领域",
            "features": {
                "keywords": [
                    "中银国际",
                    "医药",
                    "邓周宇",
                    "血液制品",
                    "原料药",
                    "中间体",
                    "细分领域"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "血液制品",
                    "原料药",
                    "中间体"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "中银国际医药首席分析师邓周宇：看好血液制品、原料药及中间体细分领域",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]